Filing Flows › TriSalus Life Sciences (TLSI) › How it makes money
How TriSalus Life Sciences (TLSI) makes money
TriSalus Life Sciences (TLSI) made $11.4M of revenue in the second quarter 2026 (Q2 2026), +2% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $11.4M | 100.0% |
| Income tax | $4K | 0.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $11.4M | +2% |
| Q1 2026 | $8.9M | -3% |
| Q4 2025 | $13.2M | +60% |
| Q3 2025 | $11.6M | +57% |
| Q2 2025 | $11.2M | +52% |
| Q1 2025 | $9.2M | +42% |
| Q4 2024 | $8.3M | +44% |
From TriSalus Life Sciences' 10-Q filed Aug 6, 2026 (on EDGAR).
Questions
How does TriSalus Life Sciences make money?
TriSalus Life Sciences (TLSI) made $11.4M of revenue in the second quarter 2026 (Q2 2026), +2% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.